← All organizations

Shanghai BDgene Co., Ltd.

For profitWebsite ↗

Also known as: Shanghai BDgene Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 30, 2025

Timeline

2010s

Jun 1, 2018
Shanghai BDgene Co., Ltd.— Founded

Drugs by trial phase (5 distinct, 10 trials)

Phase 2 (1 own, 0 via acquisition)

bd111

Phase 1 (2 own, 0 via acquisition)

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT07170254Lead sponsorN/ASep 30, 2025
NCT06474442Lead sponsorPhase 2Sep 30, 2024
NCT06465537Lead sponsorN/AJun 10, 2024
NCT06465550Lead sponsorPhase 1Jan 5, 2024
NCT06474416Lead sponsorPhase 1Sep 4, 2023
NCT05773729Lead sponsorN/AMar 31, 2023
NCT05776173Lead sponsorN/AMar 31, 2023
NCT05099094Lead sponsorEarly Phase 1Nov 25, 2021
NCT05015920Lead sponsorN/AApr 1, 2021
NCT04560790Overall official - principal investigatorPhase 1/Phase 2Dec 31, 2020
NCT04560790Lead sponsorPhase 1/Phase 2Dec 31, 2020

Details

Founded: Shanghai, CN Jun 1, 2018
Last known activity: Sep 30, 2025